To further identify the protective role of PARP1 inhibitor in vivo model of PD, 6‐month‐old α‐synucleinA53T‐tg mice were fed with Veliparib (50 μg/ml) in their drinking water for 3 months. This evidence concerns the gene PARP1 and Parkinson disease.